Is TOMDF or JEPQ a better dividend investment in 2026?

TOMDF currently yields 20000000.00% with a 5% 5-year dividend growth rate. JEPQ yields 11.47% with 5% growth. The better choice depends on your goal: TOMDF offers higher current income.

What is the dividend yield difference between TOMDF and JEPQ?

TOMDF has a forward dividend yield of 20000000.00% ($2.00/share annually). JEPQ yields 11.47% ($6.16/share annually). The yield gap is 19999988.53 percentage points.

Home › Compare › TOMDF vs JEPQ

TOMDF vs JEPQ: Dividend Comparison 2026

TOMDF yields 20000000.00% · JEPQ yields 11.47%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TOMDF wins by $4.875981653489057e+49M in total portfolio value

INVESTMENT

TIME HORIZON10 years

TOMDF

● Live price

20000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.875981653489057e+49M

Annual income

$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00

Full TOMDF calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.47%

Share price

$53.77

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.8K

Annual income

$2,269.18

Full JEPQ calculator →

Portfolio growth — TOMDF vs JEPQ

📍 TOMDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TOMDF	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TOMDF + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TOMDF pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TOMDF

Annual income on $10K today (after 15% tax)

$1,700,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

JEPQ

Annual income on $10K today (after 15% tax)

$974.55/yr

After 10yr DRIP, annual income (after tax)

$1,928.80/yr

At 15% tax rate, TOMDF beats the other by $41,445,436,407,424,570,000,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TOMDF + JEPQ for your $10,000?

TOMDF: 50%JEPQ: 50%

100% JEPQ50/50100% TOMDF

Portfolio after 10yr

$2.4379908267445285e+49M

Annual income

$24,379,668,474,955,630,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

100.00%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TOMDF buys

JEPQ buys

No recent congressional trades found for TOMDF or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTOMDFJEPQ

Forward yield	20000000.00% ✓	11.47%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4.875981653489057e+49M	$45.8K ✓
Annual income after 10y	$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓	$2,269.18
Total dividends collected	$4.875978515990276e+49M	$17.1K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: TOMDF vs JEPQ ($10,000, DRIP)

Year	TOMDF Portfolio	TOMDF Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$2,000,010,700	$2,000,000,000.00	$11,967	$1,146.53	+$2000.00M → TOMDF
2	$373,835,915,712,384	$373,833,775,700,934.50	$14,216	$1,268.02	+$373835915.70M → TOMDF
3	$65,304,953,364,964,970,000	$65,304,553,360,535,160,000.00	$16,774	$1,392.20	+$65304953364964.95M → TOMDF
4	$10,661,728,832,755,500,000,000,000	$10,661,658,956,455,399,000,000,000.00	$19,667	$1,518.21	+$10661728832755499008.00M → TOMDF
5	$1,626,767,783,781,495,000,000,000,000,000	$1,626,756,375,731,643,800,000,000,000,000.00	$22,925	$1,645.21	+$1.626767783781495e+24M → TOMDF
6	$231,974,330,054,625,100,000,000,000,000,000,000	$231,972,589,413,096,470,000,000,000,000,000,000.00	$26,578	$1,772.40	+$2.319743300546251e+29M → TOMDF
7	$30,915,106,403,922,057,000,000,000,000,000,000,000,000	$30,914,858,191,388,900,000,000,000,000,000,000,000,000.00	$30,656	$1,899.04	+$3.0915106403922057e+34M → TOMDF
8	$3,850,507,985,839,278,000,000,000,000,000,000,000,000,000,000	$3,850,474,906,675,425,000,000,000,000,000,000,000,000,000,000.00	$35,194	$2,024.45	+$3.8505079858392777e+39M → TOMDF
9	$448,210,261,035,314,200,000,000,000,000,000,000,000,000,000,000,000	$448,206,140,991,769,400,000,000,000,000,000,000,000,000,000,000,000.00	$40,228	$2,148.01	+$4.4821026103531426e+44M → TOMDF
10	$48,759,816,534,890,570,000,000,000,000,000,000,000,000,000,000,000,000,000	$48,759,336,949,911,260,000,000,000,000,000,000,000,000,000,000,000,000,000.00	$45,796	$2,269.18	+$4.875981653489057e+49M → TOMDF

TOMDF vs JEPQ: Complete Analysis 2026

TOMDF — Stock

Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv, Israel.

Full TOMDF Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this TOMDF vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TOMDF vs SCHD TOMDF vs JEPI TOMDF vs O TOMDF vs KO TOMDF vs MAIN TOMDF vs XYLD TOMDF vs QYLD TOMDF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.